A cyclodextrin-based nanoformulation achieves co-delivery of ginsenoside Rg3 and quercetin for chemo-immunotherapy in colorectal cancer

Dandan Sun; Yifang Zou; Liu  Song; Shulan Han; Hao Yang; Di Chu; Yun Dai; Jie Ma; Caitriona O'Driscoll; Zhuo  Yu; Jianfeng Guo

A cyclodextrin-based nanoformulation achieves co-delivery of ginsenoside Rg3 and quercetin for chemo-immunotherapy in colorectal cancer

Dandan Sun
, Yifang Zou
, Liu Song
, Shulan Han
, Hao Yang
, Di Chu
, Yun Dai
, Jie Ma
, Caitriona O'Driscoll
, Zhuo Yu
, Jianfeng Guo

School of Pharmacy

University College Cork
Jilin University

Research output: Contribution to journal › Article › peer-review

Original language	English (Ireland)
Pages (from-to)	378-393
Journal	Acta Pharmaceutica Sinica B
Volume	12
Issue number	1
Publication status	Published - 2022

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

SDG 3 Good Health and Well-being

Cite this

@article{0cfe91b0c7e44f0e8e17a0163b4d3619,

title = "A cyclodextrin-based nanoformulation achieves co-delivery of ginsenoside Rg3 and quercetin for chemo-immunotherapy in colorectal cancer",

author = "Dandan Sun and Yifang Zou and Liu Song and Shulan Han and Hao Yang and Di Chu and Yun Dai and Jie Ma and Caitriona O'Driscoll and Zhuo Yu and Jianfeng Guo",

year = "2022",

language = "English (Ireland)",

volume = "12",

pages = "378--393",

journal = "Acta Pharmaceutica Sinica B",

issn = "2211-3835",

publisher = "Chinese Academy of Medical Sciences",

number = "1",

}

TY - JOUR

T1 - A cyclodextrin-based nanoformulation achieves co-delivery of ginsenoside Rg3 and quercetin for chemo-immunotherapy in colorectal cancer

AU - Sun, Dandan

AU - Zou, Yifang

AU - Song, Liu

AU - Han, Shulan

AU - Yang, Hao

AU - Chu, Di

AU - Dai, Yun

AU - Ma, Jie

AU - O'Driscoll, Caitriona

AU - Yu, Zhuo

AU - Guo, Jianfeng

PY - 2022

Y1 - 2022

M3 - Article

SN - 2211-3835

VL - 12

SP - 378

EP - 393

JO - Acta Pharmaceutica Sinica B

JF - Acta Pharmaceutica Sinica B

IS - 1

ER -